Company: GMRE
Filing Date: 2025-11-13
Form Type: 424B5
Source: 0001104659-25-110926
Chunk: 33

Company: Global Medical REIT Inc.
Filing Date: 2025-11-13
Form: 424B5
Chunk 33
---
 the holders of such shares
will terminate, except the right to receive the redemption price, without interest.

In the case of any redemption of only part of
the Series B Preferred Stock at the time outstanding, the shares to be redeemed shall be selected either pro rata or by lot.

We may also redeem the Series B Preferred
Stock in limited circumstances relating to maintaining our qualification as a REIT, as described below in “— Restrictions
on Ownership and Transfer.”

Special Redemption Option upon a Change of Control

Upon the occurrence of a Change of Control (as
defined below), we may redeem for cash, in whole or in part, the Series B Preferred Stock within 120 days after the date on which
such Change of Control occurred, by paying $25.00 per share, plus any accumulated and unpaid dividends to, but excluding, the date of
redemption. If, prior to the Change of Control Conversion Date (as defined below under the caption “— Conversion Rights upon
a Change of Control”), we have provided or provide notice of redemption with respect to the Series B Preferred Stock (whether
pursuant to our optional redemption right or our special redemption option), the holders of Series B Preferred Stock will not be
permitted to exercise the conversion right described below under “— Conversion Rights upon a Change of Control” with
respect to the shares subject to such notice.

We will mail to you, if you are a record holder
of the Series B Preferred Stock, a notice of redemption no fewer than 30 days nor more than 60 days before the redemption date. We
will send the notice to your address shown on our transfer books. A failure to give notice of redemption or any defect in the notice or
in its mailing will not affect the validity of the redemption of any Series B Preferred Stock except as to the holder to whom notice
was defective. Each notice will state the following:

| · | the redemption date; |

| · | the special redemption price; |

| · | a statement setting forth the calculation of such special redemption price; |

| · | the number of shares of Series B Preferred Stock to be redeemed; |

| · | the place or places where the certificates, if any, representing shares of          
 Series B Preferred Stock are to be surrendered for payment of the redemption price; |

| · | procedures for surrendering noncertificated shares of Series B Preferred 
 Stock for payment of the redemption price;                               |

| · | that dividends on the shares of Series B Preferred Stock to